Fertin Pharma As, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NICOTINE POLACRILEX USP, with a corresponding US DMF Number 35647.
Remarkably, this DMF maintains an Active status since its submission on June 16, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 29, 2021, and payment made on June 17, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II